exhibited no cytotoxic effect against both HepG2 and J774A at concentrations of 100 μg/mL. Collectively, these findings open new avenues for the development of lipophilic-based CIP conjugates as modified ciprofloxacin derivatives for targeting bacterial biofilms and DNA gyrase.
Kumar et al. (Mon,) studied this question.